A new technique to load drugs into extracellular vesicles based on supramolecular chemistry

Extracellular vesicles (EVs) are tiny particles naturally released from cells. They are gaining attention in the field of medicine because they can carry therapeutic molecules and deliver them to specific cells with minimal immune response. This makes them ideal candidates for developing new drug delivery systems.

The Challenge of Loading Drugs into EVs

Loading drugs into EVs can be tricky. Traditional methods often use organic solvents, which can damage the EVs and cause unwanted side effects. Researchers have been looking for a better way to load drugs into EVs without using these harmful solvents.

A New Technique for Loading Drugs

In this study, scientists at Hiroshima University have developed a new technique based on supramolecular chemistry to load hydrophobic (water-repelling) molecules into EVs. This method relies on an exchange reaction that avoids the use of organic solvents. As a test case, they used a hydrophobic molecule called carborane (CB), which is a potential agent for a cancer treatment called boron neutron capture therapy (BNCT).

How It Works

The new technique successfully loaded CB into EVs (creating CB@EVs) without disrupting the EV structure or causing them to clump together. A detailed analysis showed that this method could uniformly distribute the CB within the EVs, which is important for creating effective drug formulations.

Testing the CB@EVs

The researchers tested the effectiveness of CB@EVs as agents for BNCT both in the lab and in living organisms. They found that CB@EVs outperformed other forms of CB delivery, such as liposomes and a clinically available boron agent called L-BPA. This superior performance was due to the EVs’ ability to deliver the cargo molecules efficiently, even in complex 3D cell cultures and within extracellular matrices.

Advantages of EV-Based Drug Delivery

The EV-based system showed excellent results in accumulating in tumor tissues in mouse models. The EVs could penetrate deeply into the tumors and deliver the CB molecules effectively. This targeted delivery enhanced the therapeutic benefits of BNCT, offering a significant improvement over existing methods.

Conclusion

This study highlights the potential of EVs as a versatile and effective platform for drug delivery, particularly for cancer therapies like BNCT. The new loading technique ensures that therapeutic molecules can be encapsulated without damaging the EVs, paving the way for safer and more effective treatments. As research progresses, EV-based delivery systems may revolutionize how we treat various diseases, providing more targeted and less invasive options for patients.

Kawasaki R, Oshige A, Kono N, Yamana K, Hirano H, Miura Y, Yorioka R, Bando K, Tabata A, Yasukawa N, Sadakane M, Sanada Y, Suzuki M, Takata T, Sakurai Y, Tanaka H, Yimiti D, Miyaki S, Adachi N, Mizuta R, Sasaki Y, Akiyoshi K, Hattori Y, Kirihata M, Nagasaki T, Ikeda A. (2024) Extracellular Vesicles Comprising Carborane Prepared by a Host Exchanging Reaction as a Boron Carrier for Boron Neutron Capture Therapy. ACS Appl Mater Interfaces [Epub ahead of print]. [abstract]

Leave a Reply

Your email address will not be published. Required fields are marked *

*